COVID-19-associated coagulopathy-Hypothesis: Are children protected due to enhanced thrombin inhibition by higher ₂-Macroglobulin macroglobulin (2-M)?

Wolfgang Schramm,Rainer Seitz,Lutz Guertler

JOURNAL OF THROMBOSIS AND HAEMOSTASIS（2020）

引用 11|浏览8

暂无评分

摘要

We are overwhelmed by scientific publications on clinical observations, virology and epidemiology of SARS-CoV-2 infections. There is a growing body of evidence that hypercoagulability complicates COVID-19, probably contributing to poor prognosis.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

COVID-19-associated coagulopathy-Hypothesis: Are children protected due to enhanced thrombin inhibition by higher 2-Macroglobulin macroglobulin (2-M)?

COVID-19-associated coagulopathy-Hypothesis: Are children protected due to enhanced thrombin inhibition by higher ₂-Macroglobulin macroglobulin (2-M)?